Sunday, March 25, 2012

Did Depuy unload inventory of ASRs after problems were known?

Excerpts from the Injury Board article

1.  The 2009 data from the Australian Registry showed high failure rates of the ASR

2.  In 2009, the FDA confidentially notified Depuy that they would not be approving a new ASR resurfacing system that had been in use in the UK.

3.  A letter from the FDA expressed concerns about the high levels of metal in traditional hip implants

4.  A depuy employee discussed selling out the inventories  in 2009 and 2010, until the inventories were almost depleted.

5.  products were recalled in 2010.

See article source for these claims for the actual New York Times article published on Thursday last week:  Hip Device Phaseout Followed F.D.A. Data Request

No comments:

Post a Comment